BPC-157 / TB-500 / GHK-Cu / KPV
| Specifications | |
|---|---|
| Presentation | 10 / 10 / 50 / 10 mg |
| Classification | Multi-component peptide formulation |
| Form | Lyophilized powder |
| Purity (HPLC) | Verified per lot - see COA |
| Batch / Lot | pending |
About this material
This multi-component peptide formulation combines BPC-157, a 15-amino acid synthetic peptide fragment; TB-500, a 43-amino acid synthetic peptide corresponding to the active region of thymosin beta-4; GHK-Cu, a synthetic copper-coordinated tripeptide complex composed of glycyl-L-histidyl-L-lysine; and KPV, a 3-amino acid synthetic tripeptide consisting of the lysine-proline-valine sequence. Each peptide component is independently manufactured using precision Solid-Phase Peptide Synthesis (SPPS) and purified using High-Performance Liquid Chromatography (HPLC) prior to formulation into a chemically defined lyophilized preparation.
Each production batch undergoes comprehensive analytical characterization to verify the molecular identity of all peptide components, chromatographic purity, peptide content, formulation consistency, copper complex integrity, and overall physicochemical quality prior to release. Independent component verification and standardized formulation controls support compositional accuracy and batch-to-batch reproducibility. Every production lot is accompanied by a batch-specific Certificate of Analysis (COA) documenting analytical verification, quality control review, and complete manufacturing traceability, providing a thoroughly characterized multi-peptide material for scientific and analytical laboratory research.
